Project: Spotlight series

Spotlight series
The Spotlight series features evidence-based reports on topics at the forefront of debates and challenges in the future of heart failure care.

What is the Spotlight series?

The Spotlight series features evidence-based reports on topics at the forefront of debates and challenges in the future of heart failure care. The reports highlight clinical challenges, policy issues, patient needs and best-practice case studies to support meaningful and sustainable improvements in care provision and research.

The series includes reports on the following key topics:

  • HFpEF: heart failure with preserved ejection fraction
  • Iron deficiency in heart failure
  • Telemedicine in ongoing heart failure care
  • Quality assessment in heart failure care
  • Hyperkalaemia in heart failure.

Click the buttons below to read the Spotlight series reports.

Spotlight on... HFpEF: heart failure with preserved ejection fraction Spotlight on... Iron deficiency in heart failure Spotlight on... Telemedicine in ongoing heart failure care Spotlight on... Quality assessment in heart failure care Spotlight on... Hyperkalaemia in heart failure

Who is the Spotlight series for?

The Spotlight series aims to:

  • raise awareness of the challenges surrounding heart failure
  • give confidence to patient and clinical advocates of best practice regarding heart failure challenges and potential solutions
  • galvanise decision-makers to improve heart failure policy and care.

The reports will be of interest to all those who wish to know more about the challenges surrounding heart failure, and those seeking change in the healthcare system to improve heart failure care. This includes:

  • healthcare professionals
  • people with heart failure
  • patient advocates
  • advocates of best practice and health system reform
  • organisational leaders
  • political or public officials.

Case Studies

Click the map to sort the case studies by country or view all below

Reset
The following case studies are based on research that was conducted in 2020.
Load more

Project Advisory Group

January–June 2020:

  • Josep Comín-Colet, Cardiologist, Bellvitge University Hospital, Spain
  • Joseph Gallagher, General Practitioner and Irish College of General Practitioners Clinical Lead in Cardiovascular Disease, Ireland
  • Steven Macari, Founder and President, Association Vie Et Coeur (AVEC), France
  • Sandra Mulrennan, Heart Failure Specialist Nurse, St Bartholomew’s Hospital Heart Failure Service, Barts Health NHS London, UK
  • Anne-Catherine Pouleur, Cardiologist, Université Catholique de Louvain and Cliniques Universitaires Saint Luc, Belgium
  • Patricia Vlasman, Founder and President, Let the Beat Go On, the Netherlands

September–December 2020:

  • Josep Comín-Colet, Cardiologist; Director of Cardiology, Bellvitge University Hospital, Spain
  • Salvatore Di Somma, Internist and Cardiologist; Professor of Medicine, University of Rome La Sapienza; President of Scientific Committee, Italian Association of Patients with Heart Failure (AISC), Italy
  • Naresh Kanumilli, GP with Special Interest in Cardiology, Northenden Group Practice; Community Diabetes Consultant, Manchester University Foundation Trust; Clinical Network Lead for Diabetes, Greater Manchester; Diabetes Research Lead, Greater Manchester Research Network, UK
  • Steven Macari, Founder and President, Association Vie Et Coeur (AVEC), France
  • Izabella Uchmanowicz, Nurse; President-Elect, Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology; Past‑President, Nursing and Medical Technology Section of the Polish Cardiac Society, Poland

Funders

 

The Spotlight series was developed with financial support from Vifor Pharma and Novartis Pharma.

The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma and Novartis Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.